ATE481393T1 - Neue cycloalkyl-benzothiadiazin-derivate, ihr herstellungsverfahren und die pharmazeutischen zusammensetzungen, die sie enthalten - Google Patents

Neue cycloalkyl-benzothiadiazin-derivate, ihr herstellungsverfahren und die pharmazeutischen zusammensetzungen, die sie enthalten

Info

Publication number
ATE481393T1
ATE481393T1 AT09290547T AT09290547T ATE481393T1 AT E481393 T1 ATE481393 T1 AT E481393T1 AT 09290547 T AT09290547 T AT 09290547T AT 09290547 T AT09290547 T AT 09290547T AT E481393 T1 ATE481393 T1 AT E481393T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
production process
compositions containing
benzothiadiazine derivatives
new cycloalkyl
Prior art date
Application number
AT09290547T
Other languages
English (en)
Inventor
Pierre Francotte
Tullio Pascal De
Bernard Pirotte
Laurence Danober
Pierre Lestage
Daniel-Henri Caignard
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of ATE481393T1 publication Critical patent/ATE481393T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
    • C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
    • C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
    • C07D285/26—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals
    • C07D285/28—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom substituted in position 6 or 7 by sulfamoyl or substituted sulfamoyl radicals with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT09290547T 2008-07-09 2009-07-08 Neue cycloalkyl-benzothiadiazin-derivate, ihr herstellungsverfahren und die pharmazeutischen zusammensetzungen, die sie enthalten ATE481393T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0803898A FR2933698A1 (fr) 2008-07-09 2008-07-09 Nouveaux derives de benzothiadiazines cycloalkylees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
ATE481393T1 true ATE481393T1 (de) 2010-10-15

Family

ID=40345046

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09290547T ATE481393T1 (de) 2008-07-09 2009-07-08 Neue cycloalkyl-benzothiadiazin-derivate, ihr herstellungsverfahren und die pharmazeutischen zusammensetzungen, die sie enthalten

Country Status (18)

Country Link
US (1) US7741320B2 (de)
EP (1) EP2147915B1 (de)
AR (1) AR072486A1 (de)
AT (1) ATE481393T1 (de)
AU (1) AU2009202704B2 (de)
CA (1) CA2671236C (de)
CY (1) CY1110944T1 (de)
DE (1) DE602009000183D1 (de)
DK (1) DK2147915T3 (de)
ES (1) ES2352873T3 (de)
FR (1) FR2933698A1 (de)
HR (1) HRP20100622T8 (de)
PL (1) PL2147915T3 (de)
PT (1) PT2147915E (de)
RS (1) RS51518B (de)
SI (1) SI2147915T1 (de)
TW (1) TW201006805A (de)
WO (1) WO2010004139A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013006394A1 (en) * 2011-07-01 2013-01-10 Institute For Hepatitis And Virus Research Sulfamoylbenzamide derivatives as antiviral agents against hbv infection
LT6064B (lt) 2012-10-15 2014-08-25 Vilniaus Universitetas Fluorinti benzensulfonamidai kaip karboanhidrazės inhibitoriai
CN105175284B (zh) * 2015-07-21 2017-06-16 中国药科大学 酰胺类化合物、制备方法及其医药用途
EP3597653A1 (de) * 2018-07-19 2020-01-22 Irbm S.P.A. Cyclische inhibitoren des hepatitis-c-virus

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722502B1 (fr) 1994-07-12 1996-08-23 Adir Nouveau derive de benzothiadiazine, son procede depreparation et les compositions pharmaceutiques qui le contiennent
TR200002427T2 (tr) 1998-02-18 2001-01-22 Neurosearch A/S Yeni bileşikler ve bunların pozitif ampa reseptör modülatörleri olarak kullanımı.
DE19854096A1 (de) * 1998-11-24 2000-05-25 Merck Patent Gmbh Anschlußträger für plattenförmige Mikrokomponenten
JP2005508352A (ja) * 2001-10-10 2005-03-31 ニューロサーチ、アクティーゼルスカブ 新規ベンゾチアジン誘導体、その製造方法及びその使用方法

Also Published As

Publication number Publication date
CY1110944T1 (el) 2015-06-10
EP2147915B1 (de) 2010-09-15
EP2147915A1 (de) 2010-01-27
CA2671236C (fr) 2012-06-19
US7741320B2 (en) 2010-06-22
PT2147915E (pt) 2010-10-13
AU2009202704A1 (en) 2010-01-28
US20100009974A1 (en) 2010-01-14
PL2147915T3 (pl) 2011-03-31
TW201006805A (en) 2010-02-16
HRP20100622T1 (hr) 2010-12-31
WO2010004139A1 (fr) 2010-01-14
CA2671236A1 (fr) 2010-01-09
AR072486A1 (es) 2010-09-01
ES2352873T3 (es) 2011-02-23
DE602009000183D1 (de) 2010-10-28
FR2933698A1 (fr) 2010-01-15
HRP20100622T8 (en) 2011-01-31
RS51518B (en) 2011-06-30
DK2147915T3 (da) 2010-12-20
SI2147915T1 (sl) 2010-11-30
AU2009202704B2 (en) 2013-01-17

Similar Documents

Publication Publication Date Title
LTPA2018014I1 (lt) Farmacinė kompozicija 514
PH12013502192A1 (en) Antibodies against human angiopoietin 2
IL215065A (en) Proline derivatives, their preparation process, their pharmaceutical compositions and their uses in drug preparation
BRPI0812064A2 (pt) Formulação farmacêutica, tabletes, e, processo para a produção de uma formulação farmacêutica
ATE440842T1 (de) Neue trizyklische derivate, ihr herstellungsverfahren und pharmazeutische zusammensetzungen, die sie enthalten
IL208203A (en) Annotations of 3,2-Dihydro-Pyrido-4,1-Exazine and 3,2-Dihydro-4-Oxa-9,1-Diazapananthrene, Preparation Processes and Pharmaceutical Preparations
IL195245A0 (en) Substituted prolinamides, production thereof and their use as drugs
HRP20130558T1 (hr) Derivat 17-hidroksi-17-pentafluoretil-estra-4,9(10)-dien-11-arila, postupci za njegovu proizvodnju i njegova uporaba za lijeäśenje bolesti
IL204052A (en) Annotation of 1,1,1 - Tripluoro - 2 - Hydroxy - 3 - Phenylpropane
IL206808A (en) Indolyl-pyridone history, their pharmaceutical preparations and their uses
PL2036892T3 (pl) Pochodne 1,2,4,5-tetrahydro-3H-benzazepin, sposób ich wytwarzania i zawierające je kompozycje farmaceutyczne
IL218539A (en) Annotated 4,1-Androsteadian-3-Oxo-9,6-Dihlo-16-Isoxazolidine-17-Noble N-Converted
IL212942A (en) History of Rifamycin, Methods of Preparation, Pharmaceutical Preparations Containing Them and Their Uses
ATE520658T1 (de) Neue diazeniumdiolat-derivate, ihr herstellungsverfahren und sie enthaltende pharmazeutische zusammensetzungen
PL2266619T3 (pl) Kompozycja farmaceutyczna na bazie środków chroniących wątrobę i środków prebiotycznych, ich wytwarzanie i zastosowanie
HK1156844A1 (en) Pharmaceutical composition 271 271
ATE481393T1 (de) Neue cycloalkyl-benzothiadiazin-derivate, ihr herstellungsverfahren und die pharmazeutischen zusammensetzungen, die sie enthalten
EP2119720A4 (de) Neue vinblastinderivate, ihre herstellung, anwendung und pharmazeutische zusammensetzung, die diese derivate enthalten
EP2402333A4 (de) 1,4-benzothiazepin-1-oxidderivat und pharmazeutische zusammensetzung damit
ATE444278T1 (de) Neue naphtalinderivate, ihr herstellungsverfahren und die pharmazeutischen zusammensetzungen, die sie enthalten
EP2222624A4 (de) Derivate von 4-nerolidylcatechol, pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung
EP1948162A4 (de) Pharmazeutische zusammensetzungen mit erythrin-mulungu-derivaten und herstellungsverfahren
EP2789613A4 (de) 1,4-dihydro-naphthyridin-derivat sowie pharmazeutische zusammensetzung damit und ihre verwendung
ATE480544T1 (de) Tetrazykline, ihr herstellungsverfahren, deren pharmazeutischen zusammensetzungen, die sie enthalten und deren verwendung als dopamin- rezeptoren liganden
IL200952A0 (en) Substituted sulphonamides, process for their preparation, pharmaceutical composition comprising thereof and their use

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2147915

Country of ref document: EP